GP350 CAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GP350 CAR-T, covering 2025-12-29 to 2025-12-29. Get the full timeline:
Most recent: Clinical Trial Update: GP350 CAR-T for Relapse/Refractory and Epstein-Barr Virus Infection Associated Lymphoid Neoplasms [Phase 1, Phase 2]